These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25489637)

  • 21. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.
    Šumová B; Cerezo LA; Szczuková L; Nekvindová L; Uher M; Hulejová H; Moravcová R; Grigorian M; Pavelka K; Vencovský J; Šenolt L; Závada J
    Rheumatol Int; 2019 Mar; 39(3):469-478. PubMed ID: 30392117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
    Maksymowych WP; Naides SJ; Bykerk V; Siminovitch KA; van Schaardenburg D; Boers M; Landewé R; van der Heijde D; Tak PP; Genovese MC; Weinblatt ME; Keystone EC; Zhukov OS; Abolhosn RW; Popov JM; Britsemmer K; van Kuijk AW; Marotta A
    J Rheumatol; 2014 Nov; 41(11):2104-13. PubMed ID: 25128504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of S100A4 in portopulmonary hypertension.
    Peng T; Zamanian R; Krowka MJ; Benza RL; Roberts KE; Taichman DB; Rybak D; Trotter JF; Brown RS; Fallon MB; Kawut SM;
    Biomarkers; 2009 May; 14(3):156-60. PubMed ID: 19399660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
    Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
    Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
    Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
    J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.
    Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J
    APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma.
    Liu Z; Liu H; Pan H; Du Q; Liang J
    J Int Med Res; 2013 Apr; 41(2):457-62. PubMed ID: 23781010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies.
    Cerezo LA; Kuncová K; Mann H; Tomcík M; Zámecník J; Lukanidin E; Neidhart M; Gay S; Grigorian M; Vencovsky J; Senolt L
    Rheumatology (Oxford); 2011 Oct; 50(10):1766-72. PubMed ID: 21712367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.
    de Silva Rudland S; Martin L; Roshanlall C; Winstanley J; Leinster S; Platt-Higgins A; Carroll J; West C; Barraclough R; Rudland P
    Clin Cancer Res; 2006 Feb; 12(4):1192-200. PubMed ID: 16489073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C-terminal region of S100A4 is important for its metastasis-inducing properties.
    Zhang S; Wang G; Liu D; Bao Z; Fernig DG; Rudland PS; Barraclough R
    Oncogene; 2005 Jun; 24(27):4401-11. PubMed ID: 15856021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.
    Lloyd BH; Platt-Higgins A; Rudland PS; Barraclough R
    Oncogene; 1998 Jul; 17(4):465-73. PubMed ID: 9696040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
    Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
    Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
    Knudsen LS; Klarlund M; Skjødt H; Jensen T; Ostergaard M; Jensen KE; Hansen MS; Hetland ML; Nielsen HJ; Johansen JS
    J Rheumatol; 2008 Jul; 35(7):1277-87. PubMed ID: 18597410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells.
    Takenaga K; Nakamura Y; Sakiyama S
    Oncogene; 1997 Jan; 14(3):331-7. PubMed ID: 9018119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.
    Techasen A; Namwat N; Loilome W; Duangkumpha K; Puapairoj A; Saya H; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):703-11. PubMed ID: 24867797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
    Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.
    Oida Y; Yamazaki H; Tobita K; Mukai M; Ohtani Y; Miyazaki N; Abe Y; Imaizumi T; Makuuchi H; Ueyama Y; Nakamura M
    Oncol Rep; 2006 Sep; 16(3):457-63. PubMed ID: 16865243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer.
    Kim JH; Park J
    Hum Pathol; 2014 Sep; 45(9):1830-8. PubMed ID: 24957789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.